These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11439409)

  • 1. Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration.
    Frank GK; Kaye WH; Weltzin TE; Perel J; Moss H; McConaha C; Pollice C
    Int J Eat Disord; 2001 Jul; 30(1):57-68. PubMed ID: 11439409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of serotonin function in anorexia nervosa.
    Brewerton TD; Jimerson DC
    Psychiatry Res; 1996 Apr; 62(1):31-42. PubMed ID: 8739113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
    Hadigan CM; Walsh BT; Buttinger C; Hollander E
    Biol Psychiatry; 1995 Apr; 37(8):504-11. PubMed ID: 7619973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.
    Pallanti S; Bernardi S; Quercioli L; DeCaria C; Hollander E
    CNS Spectr; 2006 Dec; 11(12):956-64. PubMed ID: 17146409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
    Benjamin J; Greenberg BD; Murphy DL
    Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
    Levitan RD; Kaplan AS; Joffe RT; Levitt AJ; Brown GM
    Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated.
    Gordon ML; Lipton RB; Brown SL; Nakraseive C; Russell M; Pollack SZ; Korn ML; Merriam A; Solomon S; van Praag HM
    Cephalalgia; 1993 Dec; 13(6):400-5. PubMed ID: 8313453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.
    Bagdy G; Arato M
    Psychopharmacology (Berl); 1998 Apr; 136(4):342-8. PubMed ID: 9600579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.
    Kaye WH; Greeno CG; Moss H; Fernstrom J; Fernstrom M; Lilenfeld LR; Weltzin TE; Mann JJ
    Arch Gen Psychiatry; 1998 Oct; 55(10):927-35. PubMed ID: 9783564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.
    Broocks A; Briggs NC; Pigott TA; Hill JL; Canter SK; Tolliver TJ; Baldemore D; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):91-103. PubMed ID: 9106905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA; Murphy DL; Sunderland T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats.
    Mazzola-Pomietto P; Aulakh CS; Huang SJ; Murphy DL
    J Pharmacol Exp Ther; 1996 Nov; 279(2):782-9. PubMed ID: 8930184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms.
    Schwartz PJ; Murphy DL; Wehr TA; Garcia-Borreguero D; Oren DA; Moul DE; Ozaki N; Snelbaker AJ; Rosenthal NE
    Arch Gen Psychiatry; 1997 Apr; 54(4):375-85. PubMed ID: 9107154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?
    Kaye WH; Gwirtsman HE; George DT; Ebert MH
    Arch Gen Psychiatry; 1991 Jun; 48(6):556-62. PubMed ID: 1710099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.
    McCann UD; Eligulashvili V; Mertl M; Murphy DL; Ricaurte GA
    Psychopharmacology (Berl); 1999 Nov; 147(1):56-65. PubMed ID: 10591869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.
    Kaye WH; Nagata T; Weltzin TE; Hsu LK; Sokol MS; McConaha C; Plotnicov KH; Weise J; Deep D
    Biol Psychiatry; 2001 Apr; 49(7):644-52. PubMed ID: 11297722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.
    Kaye WH; Weltzin TE
    J Clin Psychiatry; 1991 Dec; 52 Suppl():41-8. PubMed ID: 1752859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.